کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2083917 1545352 2013 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی بیوتکنولوژی یا زیست‌فناوری
پیش نمایش صفحه اول مقاله
Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations
چکیده انگلیسی

Liposomes have attracted extensive attention as inhalative drug delivery vehicles. The preparation of tailored liposomal formulations (i.e. nebulization stability and controlled drug release profiles) would facilitate new perspectives for the treatment of pulmonary diseases.5(6)-Carboxyfluorescein (CF)-loaded submicron liposomal formulations with varying phase transition temperatures were prepared from lipid blends in different molar ratios. Their physicochemical properties, in vitro dye release, stability to nebulization (Aeroneb® Pro) and ex vivo pulmonary dye absorption and distribution characteristics were investigated.Phase transitions of liposomes were adjusted below and above body temperature (32.9–55.2 °C). The amount of CF released from liposomes in vitro correlated well with their membrane fluidity. An increase in phase transition temperature resulted in an extended dye release profile. All formulations revealed aerodynamic particle sizes of ∼4 μm with remarkable stability when nebulized by vibrating-mesh technology (percentage of encapsulated model drug ∼80%). Analogous to the release results observed in vitro, liposomal formulations revealing phase transitions above body temperature displayed an increased pulmonary CF retention in an ex vivo lung model. Consequently, an in vitro–ex vivo correlation was established, which demonstrated an excellent agreement of the dye release results with the absorption profiles observed in the biological system (R2 ⩾ 0.91).Overall, the concept of liposomal “phase transition release” is promising for controlled pulmonary drug delivery applications. The ex vivo technique enables a reliable determination of lung-specific pharmacokinetics of drug delivery vehicles, which enhances tailored carrier preparation and testing during early formulation development.

5(6)-Carboxyfluorescein (CF)-loaded submicron liposomal formulations with varying phase transition display adjustable in vitro drug release properties with very good correlation to drug absorption in the isolated lung model.Figure optionsDownload high-quality image (108 K)Download as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Pharmaceutics and Biopharmaceutics - Volume 84, Issue 1, May 2013, Pages 106–114
نویسندگان
, , , , , ,